Happy to inform our “remote follow-up in #PragmaticTrials ” at #ACC has #SimPub to Journal of Cardiac Failure. Thanks for the team and mentorship from Adam DeVore, MD, MHS
Duke Cardiology Fellows
Duke Clinical Research Institute
Robert Mentz, MD
Gregg Fonarow MD
Javed Butler
Larry A. Allen, MD
Michael Felker
Marat Fudim, MD MHS
Adam Nelson
Adrian “WE NEED RCTS!” Hernandez
bit.ly/49uzN3e

Great to have Steve Greene all the way from Duke Clinical Research Institute here in Adelaide CSANZ reminding us of the importance of simultaneous commencement & rapid titration of HFrEF therapies. Incredible body of work highlighting gaps and importantly a path forward! Carolyn Lam

Great to have Chris Wong back in town kicking off SAHMRI Heart emerging leaders symposium. Translational data linking dietary factors with propensity for arrhythmia. Uni of Adelaide Adrian Elliott Prash Sanders ChrisBursill

Excellent summary of the renal benefits SGLT2 inhibitors by ⁦Carlos G Santos-Gallego, MD⁩ at #ADA2023
⁦Javed Butler⁩ ⁦Harriette Van Spall, MD MPH⁩ ⁦Adam Nelson⁩ ⁦Michael Wilkinson⁩ ⁦Mount Sinai Fuster Heart Hospital⁩

To prevent heart attacks & strokes we need everyone to understand their risk & how to reduce this. Funding heart health checks is an important part of this & especially important this year to implement revised guidelines for #CVD risk assessment & management. Heart Foundation

Online now: Substantial differences in chest pain management are present between women and men, from first emergency contact through to hospital discharge.
jacc.org/doi/abs/10.101…
Ambulance Victoria Ziad Nehme David Anderson Prof Karen Smith OAM

3 pills available right now to effectively lower LDL-C & reduce CV outcomes (with 2 generic)

Interesting that despite available pills,

~50% US patients with *established* atherosclerotic cardiovascular disease

are on *NO* medicines to lower LDL-C

Key ? is why